株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

世界の聴覚インプラント市場 : パイプライン分析

Hearing Implants - Medical Devices Pipeline Assessment, 2017

発行 GlobalData 商品コード 229189
出版日 ページ情報 英文 70 Pages
即納可能
価格
本日の銀行送金レート: 1USD=114.89円で換算しております。
Back to Top
世界の聴覚インプラント市場 : パイプライン分析 Hearing Implants - Medical Devices Pipeline Assessment, 2017
出版日: 2017年08月04日 ページ情報: 英文 70 Pages
概要

当レポートでは、世界の聴覚インプラント市場について調査・分析し、開発中の製品に関するデータを提供するほか、主要企業プロファイル、製品パイプライン分析など、競合情勢や製品情報も含めてお届けいたします。

第1章 目次

第2章 イントロダクション

第3章 開発中の製品

  • 開発段階別の製品パイプライン
  • セグメント別の製品パイプライン
  • 地域別の製品パイプライン
  • 制御経路別の製品パイプライン
  • 認可予定日別の製品パイプライン
  • 進行中の治験別の製品パイプライン

第4章 開発中の製品:メーカー別

  • メーカー:開発段階別の製品パイプライン
  • 開発段階別の製品パイプライン

第5章 メーカーおよび製品概要

  • Advanced Bionics, LLC
    • 会社概要
    • パイプライン製品および進行中の治験概要
  • Ceragenix Pharmaceuticals, Inc.(インアクティブ)
  • Fraunhofer Institute for Manufacturing Engineering and Automation
  • Hannover Medical School
  • Labyrinth Devices
  • MED-EL Elektromedizinische Gerate Gesellschaft m.b.H.
  • Northwestern University
  • Oticon Medical AB
  • OtoKinetics
  • Otologics, LLC (インアクティブ)
  • Ototronix, LLC
  • Sentient Medical Limited
  • Sonova Holding AG
  • The Tel Aviv Sourasky Medical Center
  • The University of Utah
  • Trinity College Dublin
  • University of Michigan Pediatric Device Consortium
  • University of Nottingham
  • University of Oklahoma
  • University of South Florida

第6章 最新動向

第7章 付録

図表

このページに掲載されている内容は最新版と異なる場合があります。詳細はお問い合わせください。

目次
Product Code: GDME0406EPD

GlobalData's Medical Devices sector report, "Hearing Implants - Medical Devices Pipeline Assessment, 2017" provides an overview of Hearing Implants currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Hearing Implants pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

  • Extensive coverage of the Hearing Implants under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Hearing Implants and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry

Reasons to buy

The report enables you to -

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of Hearing Implants under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product's current stage of development, territory and estimated launch date

Table of Contents

1 Table of Contents

1 Table of Contents 2

  • 1.1 List of Tables 4
  • 1.2 List of Figures 5

2 Introduction 6

  • 2.1 Hearing Implants Overview 6

3 Products under Development 7

  • 3.1 Hearing Implants - Pipeline Products by Stage of Development 7
  • 3.2 Hearing Implants - Pipeline Products by Segment 8
  • 3.3 Hearing Implants - Pipeline Products by Territory 9
  • 3.4 Hearing Implants - Pipeline Products by Regulatory Path 10
  • 3.5 Hearing Implants - Pipeline Products by Estimated Approval Date 11
  • 3.6 Hearing Implants - Ongoing Clinical Trials 12

4 Hearing Implants - Pipeline Products under Development by Companies 13

  • 4.1 Hearing Implants Companies - Pipeline Products by Stage of Development 13
  • 4.2 Hearing Implants - Pipeline Products by Stage of Development 14

5 Hearing Implants Companies and Product Overview 15

  • 5.1 Advanced Bionics LLC Company Overview 15
    • 5.1.1 Advanced Bionics LLC Pipeline Products & Ongoing Clinical Trials Overview 15
  • 5.2 Ceragenix Pharmaceuticals, Inc. (Inactive) Company Overview 16
    • 5.2.1 Ceragenix Pharmaceuticals, Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 16
  • 5.3 Cochlear Ltd Company Overview 17
    • 5.3.1 Cochlear Ltd Pipeline Products & Ongoing Clinical Trials Overview 17
  • 5.4 Hannover Medical School Company Overview 19
    • 5.4.1 Hannover Medical School Pipeline Products & Ongoing Clinical Trials Overview 19
  • 5.5 Huntington Medical Research Institutes Company Overview 20
    • 5.5.1 Huntington Medical Research Institutes Pipeline Products & Ongoing Clinical Trials Overview 20
  • 5.6 Labyrinth Devices Company Overview 21
    • 5.6.1 Labyrinth Devices Pipeline Products & Ongoing Clinical Trials Overview 21
  • 5.7 Northwestern University Company Overview 24
    • 5.7.1 Northwestern University Pipeline Products & Ongoing Clinical Trials Overview 24
  • 5.8 Oticon Medical AB Company Overview 25
    • 5.8.1 Oticon Medical AB Pipeline Products & Ongoing Clinical Trials Overview 25
  • 5.9 OtoKinetics (Inactive) Company Overview 29
    • 5.9.1 OtoKinetics (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 29
  • 5.10 Ototronix, LLC Company Overview 31
    • 5.10.1 Ototronix, LLC Pipeline Products & Ongoing Clinical Trials Overview 31
  • 5.11 Sonova Holding AG Company Overview 32
    • 5.11.1 Sonova Holding AG Pipeline Products & Ongoing Clinical Trials Overview 32
  • 5.12 SpecialtyCare Inc Company Overview 34
    • 5.12.1 SpecialtyCare Inc Pipeline Products & Ongoing Clinical Trials Overview 34
  • 5.13 Tel Aviv Sourasky Medical Center Company Overview 35
    • 5.13.1 Tel Aviv Sourasky Medical Center Pipeline Products & Ongoing Clinical Trials Overview 35
  • 5.14 The University of Utah Company Overview 36
    • 5.14.1 The University of Utah Pipeline Products & Ongoing Clinical Trials Overview 36
  • 5.15 Trinity College Dublin Company Overview 37
    • 5.15.1 Trinity College Dublin Pipeline Products & Ongoing Clinical Trials Overview 37
  • 5.16 University of Florida Company Overview 38
    • 5.16.1 University of Florida Pipeline Products & Ongoing Clinical Trials Overview 38
  • 5.17 University of Michigan Company Overview 39
    • 5.17.1 University of Michigan Pipeline Products & Ongoing Clinical Trials Overview 39
  • 5.18 University of Michigan Pediatric Device Consortium Company Overview 40
    • 5.18.1 University of Michigan Pediatric Device Consortium Pipeline Products & Ongoing Clinical Trials Overview 40
  • 5.19 University of Nottingham Company Overview 41
    • 5.19.1 University of Nottingham Pipeline Products & Ongoing Clinical Trials Overview 41
  • 5.20 University of Oklahoma Company Overview 42
    • 5.20.1 University of Oklahoma Pipeline Products & Ongoing Clinical Trials Overview 42
  • 5.21 University of South Florida Company Overview 43
    • 5.21.1 University of South Florida Pipeline Products & Ongoing Clinical Trials Overview 43
  • 5.22 University of Wisconsin Madison Company Overview 44
    • 5.22.1 University of Wisconsin Madison Pipeline Products & Ongoing Clinical Trials Overview 44

6 Hearing Implants- Recent Developments 45

  • 6.1 Aug 01, 2017: Intersect ENT Reports Second Quarter 2017 Results 45
  • 6.2 Jul 31, 2017: Cochlear: Chief Executive Officer & President Transition Timeline Announced 46
  • 6.3 Jul 26, 2017: Cochlear introduces the world's first Made for iPhone cochlear implant sound processor 46
  • 6.4 Jul 20, 2017: Teresa L. Kline Joins Intersect ENT's Board of Directors 48
  • 6.5 Jul 13, 2017: Sonova announces change in the Management Board 49
  • 6.6 Jun 29, 2017: Sonova announces change in the Management Board in Corporate HRM and Communications 49
  • 6.7 May 02, 2017: Intersect ENT Reports First Quarter 2017 Results 50
  • 6.8 Feb 28, 2017: Intersect ENT Reports Fourth Quarter and Full Year 2016 Results 51
  • 6.9 Feb 20, 2017: Announcing Health Canada approval of the New HiRes Ultra Cochlear Implant 52
  • 6.10 Feb 06, 2017: Knowles Reports Q4 & Full Year 2016 Financial Results and Provides Outlook for Q1 2017 53
  • 6.11 Jan 27, 2017: Knowles Appoints Helmut Vogler as Senior Vice President of Global Sales 54
  • 6.12 Jan 09, 2017: Intersect ENT Reports Preliminary Q4 and Year 2016 Revenue 54
  • 6.13 Dec 19, 2016: Unique investment by Swedish pharmaceutical company 55
  • 6.14 Nov 14, 2016: First Half Results 2016/17: Sonova with Strong Foundation for Further Growth 56
  • 6.15 Nov 02, 2016: Intersect ENT Reports Third Quarter 2016 Results 59
  • 6.16 Oct 11, 2016: Sonova announces appointment of Group Vice President Retail 60
  • 6.17 Sep 29, 2016: Cochlear launches the world's thinnest, full length perimodiolar electrode for cochlear implants 61
  • 6.18 Sep 29, 2016: Oticon Names Gary Rosenblum as New President 61
  • 6.19 Sep 29, 2016: Cochlear: Retirement Of Chief Financial Officer 62
  • 6.20 Sep 20, 2016: UNC hearing loss experts lead clinical trials of FDA-approved hearing implant 62
  • 6.21 Sep 20, 2016: NEO Tech Offers Microelectronics Miniaturization for Medical Implantable Device OEMs 63
  • 6.22 Sep 16, 2016: FDA Approves the MED-EL SYNCHRONY EAS Hearing Implant System 64
  • 6.23 Sep 15, 2016: Cochlear delivers broader insurance coverage and expanded access to cochlear implant options 64
  • 6.24 Sep 12, 2016: Introducing the New HiRes Ultra Cochlear Implant 65
  • 6.25 Aug 31, 2016: Sonova announces changes to the Management Board 66

7 Appendix 67

  • 7.1 Methodology 67
  • 7.2 About GlobalData 70
  • 7.3 Contact Us 70
  • 7.4 Disclaimer 70

List of Tables

1.1 List of Tables

  • Table 1: Hearing Implants - Pipeline Products by Stage of Development 7
  • Table 2: Hearing Implants - Pipeline Products by Segment 8
  • Table 3: Hearing Implants - Pipeline Products by Territory 9
  • Table 4: Hearing Implants - Pipeline Products by Regulatory Path 10
  • Table 5: Hearing Implants - Pipeline Products by Estimated Approval Date 11
  • Table 6: Hearing Implants - Ongoing Clinical Trials 12
  • Table 7: Hearing Implants Companies - Pipeline Products by Stage of Development 13
  • Table 8: Hearing Implants - Pipeline Products by Stage of Development 14
  • Table 9: Advanced Bionics LLC Pipeline Products & Ongoing Clinical Trials Overview 15
  • Table 10: Hires Fidelity 120 Pediatrics - Product Status 15
  • Table 11: Hires Fidelity 120 Pediatrics - Product Description 15
  • Table 12: Ceragenix Pharmaceuticals, Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 16
  • Table 13: Cerashield Coated Cochlear Inner Ear Implant - Product Status 16
  • Table 14: Cerashield Coated Cochlear Inner Ear Implant - Product Description 16
  • Table 15: Cochlear Ltd Pipeline Products & Ongoing Clinical Trials Overview 17
  • Table 16: Carina - Product Status 17
  • Table 17: Carina - Product Description 17
  • Table 18: Cochlear Nucleus 7 - Product Status 18
  • Table 19: Cochlear Nucleus 7 - Product Description 18
  • Table 20: Hannover Medical School Pipeline Products & Ongoing Clinical Trials Overview 19
  • Table 21: Optical Cochlea Stimulator - Product Status 19
  • Table 22: Optical Cochlea Stimulator - Product Description 19
  • Table 23: Huntington Medical Research Institutes Pipeline Products & Ongoing Clinical Trials Overview 20
  • Table 24: Multisite Device - Product Status 20
  • Table 25: Multisite Device - Product Description 20
  • Table 26: Labyrinth Devices Pipeline Products & Ongoing Clinical Trials Overview 21
  • Table 27: MVI Vestibular Implant System - Product Status 21
  • Table 28: MVI Vestibular Implant System - Product Description 21
  • Table 29: Labyrinth Devices - Ongoing Clinical Trials Overview 22
  • Table 30: MVI Vestibular Implant System - First-in-Human Early Feasibility Study of Safety, Tolerability and Efficacy for a Multichannel Vestibular Implant in Individuals With Bilateral Severe-to-Profound Loss of Vestibular Sensation 23
  • Table 31: Northwestern University Pipeline Products & Ongoing Clinical Trials Overview 24
  • Table 32: Cochlear Implant - Product Status 24
  • Table 33: Cochlear Implant - Product Description 24
  • Table 34: Oticon Medical AB Pipeline Products & Ongoing Clinical Trials Overview 25
  • Table 35: Neuro Cochlear Implant - Product Status 25
  • Table 36: Neuro Cochlear Implant - Product Description 25
  • Table 37: Next Generation Transcutaneous Bone Conduction Device - Product Status 26
  • Table 38: Next Generation Transcutaneous Bone Conduction Device - Product Description 26
  • Table 39: Oticon Medical AB - Ongoing Clinical Trials Overview 27
  • Table 40: Neuro Cochlear Implant - The Neuro Zti Cochlear Implant System Efficacy and Safety in Adults 28
  • Table 41: OtoKinetics (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 29
  • Table 42: Krescendo I - Product Status 29
  • Table 43: Krescendo I - Product Description 29
  • Table 44: Krescendo II - Product Status 30
  • Table 45: Krescendo II - Product Description 30
  • Table 46: Ototronix, LLC Pipeline Products & Ongoing Clinical Trials Overview 31
  • Table 47: Dalhousie Hearing Device - Product Status 31
  • Table 48: Dalhousie Hearing Device - Product Description 31
  • Table 49: Sonova Holding AG Pipeline Products & Ongoing Clinical Trials Overview 32
  • Table 50: Ingenia - Product Status 32
  • Table 51: Ingenia - Product Description 33
  • Table 52: Next Generation Cochlear Implant - Product Status 33
  • Table 53: Next Generation Cochlear Implant - Product Description 33
  • Table 54: SpecialtyCare Inc Pipeline Products & Ongoing Clinical Trials Overview 34
  • Table 55: Miniature Middle Ear Implant - Product Status 34
  • Table 56: Miniature Middle Ear Implant - Product Description 34
  • Table 57: Tel Aviv Sourasky Medical Center Pipeline Products & Ongoing Clinical Trials Overview 35
  • Table 58: Implant Electrode Extender - Product Status 35
  • Table 59: Implant Electrode Extender - Product Description 35
  • Table 60: The University of Utah Pipeline Products & Ongoing Clinical Trials Overview 36
  • Table 61: Microphone Cochlear Implant - Product Status 36
  • Table 62: Microphone Cochlear Implant - Product Description 36
  • Table 63: Trinity College Dublin Pipeline Products & Ongoing Clinical Trials Overview 37
  • Table 64: Closed-loop Cochlear Implant - Product Status 37
  • Table 65: Closed-loop Cochlear Implant - Product Description 37
  • Table 66: University of Florida Pipeline Products & Ongoing Clinical Trials Overview 38
  • Table 67: Adjustable Middle Ear Prosthesis Device - Product Status 38
  • Table 68: Adjustable Middle Ear Prosthesis Device - Product Description 38
  • Table 69: University of Michigan Pipeline Products & Ongoing Clinical Trials Overview 39
  • Table 70: Micro-Machined (MEMS) Acoustic Sensor - Product Status 39
  • Table 71: Micro-Machined (MEMS) Acoustic Sensor - Product Description 39
  • Table 72: University of Michigan Pediatric Device Consortium Pipeline Products & Ongoing Clinical Trials Overview 40
  • Table 73: Enhanced Cochlear Implant Device - Product Status 40
  • Table 74: Enhanced Cochlear Implant Device - Product Description 40
  • Table 75: University of Nottingham Pipeline Products & Ongoing Clinical Trials Overview 41
  • Table 76: Antibiotic Pellet - Product Status 41
  • Table 77: Antibiotic Pellet - Product Description 41
  • Table 78: University of Oklahoma Pipeline Products & Ongoing Clinical Trials Overview 42
  • Table 79: Totally Implantable Hearing System - Product Status 42
  • Table 80: Totally Implantable Hearing System - Product Description 42
  • Table 81: University of South Florida Pipeline Products & Ongoing Clinical Trials Overview 43
  • Table 82: Promontory Anchored Incus Replacement Prosthesis - Product Status 43
  • Table 83: Promontory Anchored Incus Replacement Prosthesis - Product Description 43
  • Table 84: University of Wisconsin Madison Pipeline Products & Ongoing Clinical Trials Overview 44
  • Table 85: Cochlear Implant - Product Status 44
  • Table 86: Cochlear Implant - Product Description 44
  • Table 87: Glossary 69

List of Figures

1.2 List of Figures

  • Figure 1: Hearing Implants - Pipeline Products by Stage of Development 7
  • Figure 2: Hearing Implants - Pipeline Products by Segment 8
  • Figure 3: Hearing Implants - Pipeline Products by Territory 9
  • Figure 4: Hearing Implants - Pipeline Products by Regulatory Path 10
  • Figure 5: Hearing Implants - Pipeline Products by Estimated Approval Date 11
  • Figure 6: Hearing Implants - Ongoing Clinical Trials 12
Back to Top